ACM
AIGH Capital Management Portfolio holdings
AUM
$213M
This Quarter Return
+3.71%
1 Year Return
+95.37%
3 Year Return
+329.16%
5 Year Return
–
10 Year Return
–
AUM
$207M
AUM Growth
+$207M
(-18%)
Cap. Flow
-$89.8M
Cap. Flow
% of AUM
-43.3%
Top 10 Holdings %
Top 10 Hldgs %
50.71%
Holding
54
New
13
Increased
10
Reduced
12
Closed
11
Top Buys
| 1 |
Humacyte
HUMA
|
$6.71M |
| 2 |
Beyond Air
XAIR
|
$6.46M |
| 3 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$6.22M |
| 4 |
Ideal Power
IPWR
|
$5.98M |
| 5 |
OneSpan
OSPN
|
$5.82M |
Top Sells
| 1 |
Adverum Biotechnologies
ADVM
|
$42.6M |
| 2 |
Aspen Aerogels
ASPN
|
$28.5M |
| 3 |
indie Semiconductor
INDI
|
$18.3M |
| 4 |
TGAN
Transphorm, Inc. Common Stock
TGAN
|
$16.9M |
| 5 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$6.22M |
Sector Composition
| 1 | Healthcare | 67.6% |
| 2 | Technology | 20.27% |
| 3 | Industrials | 12.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
scPharmaceuticals
SCPH
$295M
| $17M | 5.11% | 3,389,159 +282,364 | +9% | +$1.42M |
|
2
Ouster
OUST
$1.65B
| $14.7M | 4.43% | 1,857,114 | – | – |
|
|
ELVA
3
Electrovaya
ELVA
$243M
| $14.4M | 4.32% | 4,119,941 +766,633 | +23% | +$2.68M |
|
4
Cellectar Biosciences
CLRB
$15.5M
| $11.2M | 3.35% | 2,804,917 +889,697 | +46% | +$3.54M |
|
5
Delcath Systems
DCTH
$385M
| $11.1M | 3.33% | 2,359,728 +1,177,530 | +100% | +$5.54M |
|
6
Myomo
MYO
$39.7M
| $9.16M | 2.75% | 2,802,592 +134,302 | +5% | +$439K |
|
7
TELA Bio
TELA
$70.5M
| $8.02M | 2.41% | 1,415,255 +37,310 | +3% | +$212K |
|
|
8
Humacyte
HUMA
$245M
| $6.71M | 2.01% | +2,155,958 | New | +$6.71M |
|
|
9
Beyond Air
XAIR
$11.6M
| $6.46M | 1.94% | +3,714,458 | New | +$6.46M |
|
10
Coya Therapeutics
COYA
$110M
| $6.44M | 1.93% | 649,427 -382,550 | -37% | -$3.79M |
|
11
Fennec Pharmaceuticals
FENC
$247M
| $6.34M | 1.9% | 570,332 +240,962 | +73% | +$2.68M |
|
|
12
Ideal Power
IPWR
$44.5M
| $6.23M | 1.87% | 700,000 +671,678 | +2,372% | +$5.98M |
|
|
EGRX
13
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $6.22M | 1.87% | +1,186,509 | New | +$6.22M |
|
|
THTX
14
Theratechnologies
THTX
$149M
| $6.16M | 1.85% | 3,725,204 +5,902 | +0.2% | +$9.75K |
|
|
ALIM
15
DELISTED
Alimera Sciences, Inc.
ALIM
| $5.93M | 1.78% | 1,520,359 -705,709 | -32% | -$2.75M |
|
|
16
OneSpan
OSPN
$580M
| $5.82M | 1.75% | +500,000 | New | +$5.82M |
|
|
PROF
17
Profound Medical
PROF
$134M
| $5.52M | 1.66% | 646,733 | – | – |
|
|
INFN
18
DELISTED
Infinera Corporation Common Stock
INFN
| $5.36M | 1.61% | +889,284 | New | +$5.36M |
|
19
Intellicheck
IDN
$109M
| $5.27M | 1.58% | +1,514,026 | New | +$5.27M |
|
20
Lightpath Technologies
LPTH
$230M
| $4.86M | 1.46% | 3,523,932 -200,000 | -5% | -$276K |
|
21
BK Technologies
BKTI
$264M
| $4.83M | 1.45% | 330,896 | – | – |
|
22
Immix Biopharma
IMMX
$64M
| $4.77M | 1.43% | +1,555,000 | New | +$4.77M |
|
23
Biodesix
BDSX
$62.6M
| $4.75M | 1.43% | 3,321,085 -1,337,861 | -29% | -$1.91M |
|
24
Red Cat Holdings
RCAT
$892M
| $3.8M | 1.14% | 4,964,873 -61,231 | -1% | -$46.8K |
|
25
Aprea Therapeutics
APRE
$9.09M
| $3.5M | 1.05% | 539,300 +190,000 | +54% | +$1.23M |
|